Immunotherapy in Ovarian Cancer-Where Are We Going?

被引：0
|
作者：
Markman, Maurie [1 ,2 ]
机构：
[1] Canc Treatment Ctr Amer, Philadelphia, PA USA
[2] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY | 2016年 / 12卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Over the past decade there have been major advances in the use of several innovative immunotherapeutic strategies in the management of a number of malignancies. Unfortunately, to date, despite considerable efforts in ovarian cancer in this therapeutic domain there has been limited evidence of clinical utility. Provocative research in vaccine-based treatments and early signs of efficacy for checkpoint inhibitors hold the potential promise that this situation will change in the not-so-distant future.
引用
下载
收藏
页码：13 / 15
页数：3
相关论文
共 50 条
  • [21] Radiotherapy for small-cell lung cancer-Where are we heading?
    Bayman, N. A.
    Sheikh, H.
    Kularatne, B.
    Lorigan, P.
    Blackhall, F.
    Thatcher, N.
    Faivre-Finn, C.
    LUNG CANCER, 2009, 63 (03) : 307 - 314
  • [22] Prostate Cancer: Where We Have Been, Where We Are, and Where We Are Going
    D'Amico, Anthony V.
    SEMINARS IN RADIATION ONCOLOGY, 2013, 23 (03) : 155 - 156
  • [23] Prostate Cancer: Where We Have Been, Where We Are, Where We Are Going
    Michael K. Brawer
    World Journal of Surgery, 2000, 24 : 1200 - 1204
  • [24] Prostate cancer: Where we have been, where we are, where we are going
    Brawer, MK
    WORLD JOURNAL OF SURGERY, 2000, 24 (10) : 1200 - 1204
  • [25] Conservative Management of Vulvar Cancer-Where Should We Draw the Line?
    Hacker, Neville F.
    Barlow, Ellen L.
    CANCERS, 2024, 16 (17)
  • [26] THE HISTORY OF CANCER-WHERE WE ARE AT THE 100TH BIRTHDAY OF THE AMERICAN CANCER SOCIETY
    Elefsiniotis, I. S.
    Tsoumakas, K.
    Kapritsou, M.
    Magaziotou, I
    Derdemezi, A.
    Mariolis-Sapsakos, T.
    Katsoulas, Th
    Konstantinou, E. A.
    GASTROENTEROLOGY NURSING, 2014, 37 (01) : 107 - 107
  • [27] Cancer vaccines: Where are we going?
    Cebon, Jonathan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2010, 6 : S9 - S15
  • [28] Cancer immunotherapy with peptide-based vaccines: What have we achieved? - Where are we going?
    Parmiani, G
    Castelli, C
    Dalerba, P
    Mortarini, R
    Rivoltini, L
    Marincola, FM
    Anichini, A
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (11): : 805 - 818
  • [29] Advanced bladder cancer ... Where are we now and where are we going?
    Sarosdy, MF
    Machtens, S
    WORLD JOURNAL OF UROLOGY, 2002, 20 (03) : 143 - 143
  • [30] Radiological evaluation of response to immunotherapy in brain tumors: Where are we now and where are we going?
    Porcu, Michele
    Solinas, Cinzia
    Garofalo, Paolo
    de Azambuja, Evandro
    Scartozzi, Mario
    Willard-Gallo, Karen
    Preusser, Matthias
    Saba, Luca
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 126 : 135 - 144
12345